aTyr Pharma | SC 13G:超过5%持股股东披露文件-Point72 Asset Management, L.P.(6.2%),Point72 Capital Advisors, Inc.(6.2%)等
aTyr Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Federated Hermes, Inc.(19.35%),Voting Shares Irrevocable Trust(19.35%)等
aTyr Pharma | 4:持股变动声明-董事 SCHIMMEL PAUL
4:持股变动声明-高管 DENYES NANCY
aTyr Pharma | 4:持股变动声明-董事 COUGHLIN TIMOTHY
aTyr Pharma | 4:持股变动声明-高管 Broadfoot Jill Marie
aTyr Pharma | 4:持股变动声明-高管 Shukla Sanjay
aTyr Pharma | 4:持股变动声明-董事 CLARKE JOHN K
aTyr Pharma | 4:持股变动声明-董事 Gross Jane A
aTyr Pharma | 4:持股变动声明-董事 Lucas Svetlana
aTyr Pharma | 4:持股变动声明-董事 SCHIMMEL PAUL
aTyr Pharma | 4:持股变动声明-董事 Zaknoen Sara
aTyr Pharma | 4:持股变动声明-董事 COUGHLIN TIMOTHY
aTyr Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Laurence W. Lytton(1.0%)
aTyr Pharma | SC 13G/A:超过5%持股股东披露文件(修正)
aTyr Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
aTyr Pharma | 4:持股变动声明-高管 Shukla Sanjay
aTyr Pharma | 4:持股变动声明-高管 Broadfoot Jill Marie
aTyr Pharma | 4:持股变动声明-高管 DENYES NANCY
aTyr Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Federated Hermes, Inc.(17.37%),Voting Shares Irrevocable Trust(17.37%)等
暂无数据
暂无数据